MANUFACTURERS LIFE INSURANCE COMPANY, THE - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$93,000
-41.5%
35,664
+40.5%
0.00%
Q2 2018$159,000
-6.5%
25,385
+24.4%
0.00%
Q1 2018$170,000
-19.4%
20,406
-1.7%
0.00%
Q4 2017$211,000
+19.2%
20,762
+6.8%
0.00%
Q3 2017$177,000
+3440.0%
19,433
+3009.3%
0.00%
Q2 2017$5,000
-83.9%
625
-85.4%
0.00%
Q1 2017$31,000
+933.3%
4,270
+714.9%
0.00%
Q4 2016$3,0000.0%5240.0%0.00%
Q3 2016$3,000
-40.0%
5240.0%0.00%
Q2 2016$5,000
-66.7%
524
-65.0%
0.00%
Q1 2016$15,0001,4980.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 666,729$14,008,0009.60%
DSC Advisors, L.P. 907,358$17,157,0008.33%
DAFNA Capital Management LLC 63,400$1,332,0001.32%
WALL STREET ASSOCIATES 199,343$4,188,0000.80%
Perceptive Advisors 742,132$15,592,0000.62%
EMERALD MUTUAL FUND ADVISERS TRUST 331,142$6,957,0000.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 458,332$9,630,0000.37%
EMERALD ADVISERS, LLC 321,313$6,751,0000.35%
Tourbillon Capital Partners, L.P. 611,686$12,852,0000.34%
DSC Advisors, L.P. 31,240$656,0000.32%
View complete list of NEOS THERAPEUTICS INC shareholders